Recent Updates
Recently added Catalysts
ARAY Positive Sentiment

Accuray Innovation & Partnership Hub

Key Takeaway: Accuray has inaugurated its Innovation & Partnership Hub in Genolier, Switzerland, emphasizing its commitment to radiotherapy and cancer treatment innovation. The facility, located within the Genolier Innovation Hub, will serve as a training center for Accuray's advanced systems, including the Radixact® and upcoming CyberKnife® Systems. The event was attended by local leaders and stakeholders, highlighting community support.
Price reaction · baseline $2.21 (2024-04-18 close) · hit pre-market · clean, no other ARAY news in the window
day 0 close · peak
-3.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Inauguration of the Innovation & Partnership Hub in Switzerland.
  • Strategic location enhances collaboration in cancer treatment innovation.
  • Facility serves as a crucial training center for advanced radiotherapy systems.
  • Support from local leaders and stakeholders indicates strong community backing.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~10 mo
Medium dilution risk
Lead asset
5Fluorouracile and Mitomycin-C
Phase 2 · Locally Advanced Anal Canal Cancer

Full Press Release Details

On April 16, Accuray inaugurated its Innovation & Partnership Hub in Genolier, Switzerland, reaffirming its commitment to the radiotherapy field as well as the Canton of Vaud. Positioned strategically within the Genolier Innovation Hub, the new facility capitalizes on the proximity of hospital groups and many investments by the Canton of Vaud making it a region of excellence in the management of benign and malignant tumors. This environment is expected to foster collaborations driving cancer treatment innovation.
Spanning 500m², the Hub is serving as a crucial training center for Accuray systems renowned for their precision and accuracy in the delivery of radiation. It features today the Radixact® Systems , along with two training rooms and a high-tech studio for online training. In the summer, the CyberKnife® System will be installed.
The event gathered approximately 80 people who enjoyed presentations, a cutting-ribbon ceremony and a guided tour of Accuray facility. We want to thank André Darmon, Mr Le Syndic, City of Genolier, Antoine Hubert, Delegate of the Board of Directors, AEVIS Victoria, Anna Gräbner, CEO of the Genolier Innovation Hub, Prof Oscar Matzinger, Medical Director of the Swiss Radio Oncology Network, and all our guests who honored us with their presence at this crucial milestone in our journey. The support and enthusiasm made this day unforgettable.

Frequently Asked Questions

What is the purpose of Accuray's new Innovation Hub?

The Innovation Hub aims to foster collaborations and drive innovation in cancer treatment.

Where is Accuray's Innovation & Partnership Hub located?

The Hub is located in Genolier, Switzerland, within the Genolier Innovation Hub.

What systems will be featured at the Hub?

The Hub will feature the Radixact® Systems and will install the CyberKnife® System in summer.

Who attended the inauguration event?

Approximately 80 people, including local leaders and stakeholders, attended the inauguration.

Last updated: Apr 19, 2024